Lung Cancer Webinars
Bringing experiences together
Welcome to the Siemens Healthineers Lung Cancer Webinar series, designed to provide healthcare professionals, researchers, and patients with the latest information and insights on lung cancer screening, diagnosis and treatment. Our webinars feature leading experts in the field of oncology who share their perspectives on the latest advancements in lung cancer.
ECR 2023
Cancer Day
Lung screening – from clinical studies to established programs
In this video, the panel of experts will share their insights and perspectives on the current status of lung cancer screening, including the latest advancements in technology, best practices for patient selection, and ongoing research efforts.
Agenda
- Sebastian Schmidt, Senior Manager for Medical Affairs at Siemens Healthineers Forchheim
“ Update on lung screening in Europe” - Ante Marušić, MD, PhD, LCS Team, Zagreb, Croatia
“Three years after the first lung screening: experience sharing from Croatia” - Rozemarijn Vliegenthart, MD, PhD, Professor of Radiology at the University of Groningen, the Netherlands
“Lung screening: current challenges and solutions” - Felix Herth, MD, PhD, Professor of Internal Medicine and Pulmonology at the University of Heidelberg, Germany
“The role of pulmonology in lung cancer screening”
Learning Objectives
- To understand the status of lung cancer screening programs in the EU
- To learn which steps are to be considered in setting up a lung screening program
- To understand the learnings in setting up a lung screening program
- To learn how AI can be used in lung screening
- To understand the role of pulmonology in the lung cancer screening process
ECR panel discussion
What can the radiology community do to drive lung screening in Europe?
On Wednesday, March 1, from 17:00 to 17:30, an online panel discussion took place to address the recent recommendation by the EU council to extend screening programs to lung cancer. Lung screening programs have been established in many European countries, but their implementation and effectiveness vary due to differences in healthcare systems per country. The panel discussed topics such as the importance of screening, the current state of lung screening programs, the role of radiologists in driving lung screening in their respective countries and the use of AI in lung screening.
Agenda
- Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers, Germany
- Prof. Marie Pierre Revel, Head of Radiology department at Cochin hospital, France
- Prof. Dr. med. Hans-Ulrich Kauczor, Head of clinic for diagnostic and interventional radiology at Heidelberg University Hospital, Germany
- Mélisande Rouger, ESR moderator
Learning Objectives
- To understand the main benefit of AI in lung cancer screening
- To evaluate the importance of lung screening and the role of radiologists in driving its implementation
- To analyze the potential and challenges of using AI in lung cancer screening
AI in Lung Screening
The use of AI in lung cancer diagnosis
Prof. Grenier is a leading expert in radiology and imaging, with a particular focus on lung cancer screening. He is currently working at Hôpital Foch in Suresnes, France, where his research focuses on improving medical imaging techniques and protocols for the early detection of lung cancer. With the advent of AI and machine learning technologies, Prof. Grenier has been exploring their potential applications in lung screening to improve accuracy, efficiency, and ultimately patient outcomes. His work contributes to advancing our understanding of how AI can be used to enhance medical imaging and improve patient outcomes in lung cancer screening.
Learning Objectives
- To understand how AI can improve lung cancer screening by analyzing medical imaging data
- To identify non-oncological factors that should be considered when performing lung cancer screening
Experience Sharing
Lung Cancer Screening in Europe
The life-saving potential of early lung cancer detection1 is increasingly recognized, and individual countries have already started to implement screening programs.
What can we learn from these countries?
Target group: Medical (e.g., radiologists, pulmonologists, and other referral and specialty physicians) and policy stakeholders
Agenda
- General considerations: Steps towards the implementation of lung cancer screening programs at European level (Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers)
- Lung cancer screening in the UK: Experiences and insights in a trailer-based program (Professor Richard Booton2 PhD FRCP, Consultant Respiratory Physician, Honorary MAHSC Clinical Professor & Clinical Director, Directorate of Lung Cancer & Thoracic Surgery, North West Lung Centre, Wythenshawe Hospital, Manchester, UK)
- Lung cancer screening in Poland: Organizational program set-up (Joanna Bidzińska2, Ph.D., EMBA, Project coordinator of National Lung Cancer Screening in the University Clinical Centre in Gdańsk for the northern Macroregion of Poland)
- Q&A
Learning Objectives
- Why is lung cancer screening a critical factor in reducing lung cancer mortality?
- What is the status of lung cancer screening programs in the EU?
- How can a screening program be implemented?
- What are possible approaches on how to set up a lung cancer screening program?
- What are the lessons or pitfalls?
ECR 2022
Focus on Radiology: Lung cancer screening and its role in radiology practice
At ECR 2022, we held our lunch symposium titled "Lung cancer screening and its role in radiology practice", which was very well received.
Agenda
- Experience with the implementation of LCS in Poland: How Poland set up their lung cancer screening program, Radiologist and lung cancer screening. Polish experience (Prof. Witold Rzyman2, Gdansk / Poland)
- CT Technologies for Lung Cancer Screening: Which technology parameters are important to achieve good quality images at ultra low dose, what needs to be considered in finding your local LCS protocol (Prof. Dr. Marc Kachelrieß2, Heidelberg / Germany)
- The role of Artificial Intelligence (AI) in a LCS Program: Identifying smoking-related disease on LCS CT scans, the role of AI in LCS (Prof. Philippe Grenier2, Suresnes, France)
- Q&A
Did this information help you?
https://ers.app.box.com/v/ERS-ESR-Lung-Cancer-Factsheet | Accessed 27.09.2022
Speakers signed a speaker contract